Frederick Foley, PhD

home / authors / frederick-foley-phd

Articles

Final Thoughts: Improving QoL in Multiple Sclerosis

Final Thoughts: Improving QoL in Multiple Sclerosis

Patricia Coyle, MD;June Halper, MSN, APC-C, MSCN, FAAN;Frederick Foley, PhD
February 5th 2021
Optimistic Outlook in Treating Multiple Sclerosis

Optimistic Outlook in Treating Multiple Sclerosis

Patricia Coyle, MD;June Halper, MSN, APC-C, MSCN, FAAN;Frederick Foley, PhD
February 5th 2021
Patient Support Networks for Multiple Sclerosis

Patient Support Networks for Multiple Sclerosis

Patricia Coyle, MD;June Halper, MSN, APC-C, MSCN, FAAN;Frederick Foley, PhD
February 5th 2021
OPTIMUM Trial for Multiple Sclerosis

OPTIMUM Trial for Multiple Sclerosis

Patricia Coyle, MD;June Halper, MSN, APC-C, MSCN, FAAN;Frederick Foley, PhD
February 5th 2021
TRIUMPHANT-MS Trial for Multiple Sclerosis

TRIUMPHANT-MS Trial for Multiple Sclerosis

Patricia Coyle, MD;June Halper, MSN, APC-C, MSCN, FAAN;Frederick Foley, PhD
February 5th 2021
Multiple Sclerosis Fatigue

Multiple Sclerosis Fatigue

Patricia Coyle, MD;June Halper, MSN, APC-C, MSCN, FAAN;Frederick Foley, PhD
February 5th 2021
Quality of Life Issues:  Cognitive Changes with MS

Quality of Life Issues:  Cognitive Changes with MS

Patricia Coyle, MD;June Halper, MSN, APC-C, MSCN, FAAN;Frederick Foley, PhD
February 5th 2021
Patient’s Journey of Therapies for Multiple Sclerosis

Patient’s Journey of Therapies for Multiple Sclerosis

Patricia Coyle, MD;June Halper, MSN, APC-C, MSCN, FAAN;Frederick Foley, PhD
February 5th 2021
Treatment Options Available for Multiple Sclerosis

Treatment Options Available for Multiple Sclerosis

Patricia Coyle, MD;June Halper, MSN, APC-C, MSCN, FAAN;Frederick Foley, PhD
February 5th 2021
Managing Psychological Symptoms of Multiple Sclerosis

Managing Psychological Symptoms of Multiple Sclerosis

Patricia Coyle, MD;June Halper, MSN, APC-C, MSCN, FAAN;Frederick Foley, PhD
February 5th 2021
Psychological Impact of Multiple Sclerosis

Psychological Impact of Multiple Sclerosis

Patricia Coyle, MD;June Halper, MSN, APC-C, MSCN, FAAN;Frederick Foley, PhD
February 3rd 2021
Patient’s Journey: Diagnosis of Multiple Sclerosis

Patient’s Journey: Diagnosis of Multiple Sclerosis

Patricia Coyle, MD;June Halper, MSN, APC-C, MSCN, FAAN;Frederick Foley, PhD
January 25th 2021

Latest Updated Articles

Jannis Müller, MD, MSc (Credit: LinkedIn)
Published: May 14th 2025 | Updated: May 16th 2025
Observed Differences in PIRA Definition Call for More Standardized Agreement on Term
Giulia Fadda, MD (Credit: Ottawa Hospital Research Institute)
Published: May 12th 2025 | Updated: May 13th 2025
Serum Neurofilament Light Chain Limited in Predicting MOGAD Attacks but Correlates With Attack Severity
FDA Approves Diazoxide Choline Extended-Release Tablets for Hyperphagia in Prader-Willi Syndrome
Published: March 27th 2025 | Updated: March 28th 2025
FDA Approves Diazoxide Choline Extended-Release Tablets for Hyperphagia in Prader-Willi Syndrome
BTK Inhibitor Tolebrutinib Shows Greater Effectiveness in Multiple Sclerosis with Higher Paramagnetic Rim Lesion Counts
Published: March 4th 2025 | Updated: March 19th 2025
BTK Inhibitor Tolebrutinib Shows Greater Effectiveness in Multiple Sclerosis with Higher Paramagnetic Rim Lesion Counts
FDA Approves Vertex Pharmaceuticals' Suzetrigine for Acute Pain Management
Published: January 30th 2025 | Updated: February 21st 2025
FDA Approves Vertex Pharmaceuticals' Suzetrigine for Acute Pain Management
Cerebrospinal Fluid Lipids Shows Promise as Biomarkers for Differentiating NMOSD and MS
Published: February 15th 2025 | Updated: February 18th 2025
Cerebrospinal Fluid Lipids Shows Promise as Biomarkers for Differentiating NMOSD and MS
© 2025 MJH Life Sciences

All rights reserved.